Skip to main content
OpenTrials
Completed

NCT Number: NCT07654699

Active and Mindful - A Mind-Body Programme for People With Multiple Sclerosis: a Feasibility Study Protocol

The purpose of this exploratory study is to evaluate the feasibility and acceptability of the "Active and Mindful" home-based mind-body exercise program for individuals diagnosed with Multiple Sclerosis (MS) in Portugal and Spain.

Multiple Sclerosis often leads to physical and psychological challenges that impact health-related quality of life. Mind-body exercise programs combined with remote supervision present an accessible, flexible alternative to traditional center-based rehabilitation. This study assesses the practicality of implementing a 9-month online intervention delivered via video-conferencing, focusing on recruitment rates, retention, participant attendance, and overall satisfaction. Secondarily, the study explores pre-to-post changes in clinical and psychological indicators such as perceived physical exertion and health-related quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Departamento de Desporto e Saúde, Escola de Saúde e Desenvolvimento Humano, Universidade de Évora

Evora, 7000-727, Portugal

About this study

Background:

Multiple Sclerosis (MS) is a chronic, progressive neurological condition that requires ongoing management to maintain physical functioning and psychological well-being. Exercising at home using digital health solutions offers a viable pathway to increase adherence and overcome logistical barriers (such as transportation or geographic isolation) often faced by clinical populations. This exploratory study investigates the "Active and Mindful" program, a remotely supervised, home-based intervention designed specifically to accommodate the functional variations of people living with MS.

Objectives:

  • To determine the feasibility of the program through quantitative benchmarks, specifically recruitment efficiency, attrition (retention rate), and global session attendance.
  • To evaluate participant acceptability and satisfaction with the synchronous group dynamic.
  • To collect preliminary exploratory data on patient-reported outcomes, including perceived exertion during sessions and health-related quality of life domains.

Methodology:

The study utilized a non-randomized, single-group, interventional design spanning a total duration of 9 months. Individuals with MS were recruited via digital interest forms and institutional channels across Portugal (in collaboration with the Sociedade Portuguesa de Esclerose Múltipla - SPEM) and Spain (in collaboration with the Asociación de Familiares y Afectados de Esclerosis Multiple - AFAEM).

The intervention was structured into distinct functional tiers to ensure physical safety and progressive adaptation:

  • Synchronous Phase: Live, exercise sessions conducted via the ZOOM platform in small groups ranging from 3 to 8 participants, organized according to their baseline functional capacity. Sessions were held twice a week and incorporated physical fitness, adapted Pilates, Tai-Chi, mindfulness protocols, and guided relaxation techniques.
  • Asynchronous Phase: During the latter half of the program, participants were progressively introduced to and integrated with digital video resources hosted on a dedicated web platform, promoting independent home practice.
  • Session Monitoring: To assess the specific feasibility of these pre-recorded video sessions, participants completed study-specific session evaluation forms.

Data collection and Timeline:

Quantitative data and validated health surveys were administered at three distinct time points to capture the progression of the cohort:

  • Baseline(T0): Collected before the first exercise session to record sociodemographic characteristics, clinical history, and initial status.
  • Midpoint Assessment (T1): Conducted at approximately 4.5 months to monitor early compliance and initial shifts in perceived effort.
  • Post-test (T2): Completed at month 9 to evaluate the terminal outcomes, overall compliance, retention metrics, and final system satisfaction.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients diagnosed with Multiple Sclerosis living in Portugal or Spain;
  • Expanded Disability Status Scale (EDSS) score below 8;
  • First to register on the online inscription survey (subject to limited spots)
  • Time availability to comply with the session schedules;
  • Access to compatible digital devices with visual feedback (Camera) and reliable internet connectivity;
  • Ability to install and use the ZOOM platform with the camera turned on.

Exclusion criteria

  • Significant medical comorbidities that impact or prevent safe exercise participation;
  • Pregnant women.

Treatment and study plan

Active and Mindful Program

Other

An online exercise program (combining synchronous and asynchronous sessions) conducted in a small groups (3 to 8 participants) tailored to functional levels. Sessions were held twice a week for 9months, including physical fitness, Pilates, Tai-Chi, mindfulness, and relaxation techniques. In the final phase, asynchronous video resources on a web platform were introduced

Primary outcomes

  1. Recruitment Rate

    Time frame: Baseline (T0)

    Percentage of participants recruited out of the total expressions of interest received.

  2. Retention Rate

    Time frame: Post-intervention (T2 - 9 months)

    Percentage of participants who completed the intervention and the final follow-up assessments

  3. Global Attendance Rate

    Time frame: Through the 9 month intervention

    Mean percentage of exercise sessions attended by the participants throughout the program.

  4. Program Satisfaction and Acceptability

    Time frame: At the end of every training session throughout the 9-month intervention period.

    Participant satisfaction scores measured through a feedback questionnaire (scored on a 1 to 5 Likert scale, where higher scores indicate higher satisfaction).

  5. Perceived Exertion (Borg RPE)

    Time frame: At the end of every training session throughout the 9-month intervention period.

    Assessment of physical effort intensity during exercise sessions using the Borg Rating of Perceived Exertion (RPE) scale 0-10. Higher scores indicate higher physical exertion.

Secondary outcomes

  1. General Health-Related Quality of Life (SF-36)

    Time frame: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)

    Generic health status questionnaire covering 8 domains. Subscale scores range from 0 to 100, where higher scores indicate better health status and quality of life.

  2. Multiple Sclerosis-Specific Quality of Life (MSQOL-54)

    Time frame: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)

    Evaluation of MS-specific quality of life across physical and mental health composites. Scores range from 0 to 100, where higher scores represent superior quality of life.

  3. Modified Fatigue Impact Scale (MFIS)

    Time frame: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)

    Assessment of the impact of fatigue on physical, cognitive, and psychosocial functioning using the Modified Fatigue Impact Scale (MFIS). Total score ranges from 0 to 84, where higher scores indicate a greater negative impact of fatigue. Scores above 38 indicate significant clinical fatigue.

  4. Hospital Anxiety and Depression Scale (HADS)

    Time frame: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)

    Evaluation of psychological distress using the Hospital Anxiety and Depression Scale (HADS), comprising two subscales: Anxiety (HADS-A) and Depression (HADS-D). Each subscale scores from 0 to 21, where higher scores indicate greater severity of symptoms (worse outcome).

  5. Activities-Specific Balance Confidence (ABC)

    Time frame: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)

    Self-reported scale measuring a patient's confidence in maintaining balance during various daily ambulatory activities. Scores range from 0% to 100%, where higher percentages indicate greater balance confidence.

  6. Mindfulness Attention Awareness Scale (MAAS)

    Time frame: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)

    Assessment of mindful presence and awareness in daily life using the Mindful Attention Awareness Scale (MAAS). Total score ranges from 1 to 6 (calculated as a mean of items), where higher scores indicate higher dispositional mindfulness.

  7. Interoceptive Awareness (MAIA)

    Time frame: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)

    Evaluation of body awareness and connection through the Multidimensional Assessment of Interoceptive Awareness (MAIA). It measures 8 subscales scored from 0 to 5, with higher scores indicating better interoceptive awareness and body trusting.

  8. Physical Activity Levels (IPAQ)

    Time frame: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)

    Assessment of total physical activity over the previous 7 days using the International Physical Activity Questionnaire (IPAQ). Outcomes are reported as continuous scores in MET-minutes/week or categorized into Low, Moderate, or High activity groups.

  9. Pain Severity and Interference (BPI)

    Time frame: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)

    Evaluation of pain intensity and its impact on daily functional activities using the Brief Pain Inventory (BPI). It generates two major subscales: Pain Severity (0-10) and Pain Interference (0-10), where higher scores denote worse pain and higher functional impairment.

Other outcomes

  1. State Mindfulness Scale (SMS)

    Time frame: Baseline (T0), Midpoint (T1 - 4.5 months), and Post-intervention (T2 - 9 months)

    Measurement of state mindfulness experienced during or immediately after intervention sessions using the State Mindfulness Scale. The SMS is a 21-item self-report measure with a 5-point Likert-type scale (1 = not at all to 5 = very well), comprising two subscales: State Mindfulness of Mind (15 items) and State Mindfulness of Body (6 items). Total scores range from 21 to 105, where higher scores reflect greater state mindfulness (better outcome).

Sponsors and collaborators

Lead sponsor

Catarina Alexandra Nunes Martins

Other

Collaborators

  • Asociación de Familiares y Afectados de Esclerosis Múltiple
  • Comprehensive Health Research Center
  • Sociedade Portuguesa de Esclerose Múltipla
  • University of Évora

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jun 17, 2026
Registry last updated
Jun 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.